PODCAST

Nephrology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Patient Counseling in C3GN: From Disease Education to...

Nephrology ·

2025/05/02

Guest: Gates B. Colbert, MD When counseling patients with C3 glomerulonephritis (C3GN), an open dialogue, education, and individualized treatment planning are crucial for optimal care. Join Dr. Gates Colbert as he shares practical strategies to foster trust, encourage engagement, and support patients navigating a complex and often unpredictable condition. Dr. Colbert is an Assistant Clinical Professor at Texas A&M College of Medicine and a practicing physician with the Kidney and

00:00:00

Challenges in C3GN Care: Managing Relapsing and...

Nephrology ·

2025/04/28

Guest: Gates B. Colbert, MD Managing patients with relapsing or treatment-resistant C3 glomerulopathy (C3GN) often presents significant clinical and emotional challenges. Join Dr. Gates Colbert as he discusses how clinicians can set realistic expectations for patients, collaboratively tailor treatment plans, and mitigate the impacts of itensified treatment regiments on quality of life. Dr. Colbert is a Clinical Assistant Professor at Texas A&M College of Medicine and a practicing

00:00:00

Tailoring Treatment for Optimal Outcomes in Patients...

Nephrology ·

2025/02/14

Host: Bernhard Hellmich, MD Guest: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Optimizing AAV Outcomes: Maintenance Therapies

Nephrology ·

2025/02/14

Host: Bernhard Hellmich, MD Guest: Silke R. Brix, MD, MRCP, SCPR Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Don't Miss It! Rapid & Accurate AAV Diagnosis

Nephrology ·

2025/02/14

Guest: Silke R. Brix, MD, MRCP, SCPR Host: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Managing Patients With AAV in the Rheumatology Clinic

Nephrology ·

2025/02/14

Host: Andreas Kronbichler, MD Guest: Bernhard Hellmich, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Elevating Care for Patients With Severe Renal Disease...

Nephrology ·

2025/02/14

Host: Silke R. Brix, MD, MRCP, SCPR Guest: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Implementing the SOC Induction Therapies in AAV

Nephrology ·

2025/02/14

Host: Silke R. Brix, MD, MRCP, SCPR Guest: Bernhard Hellmich, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Rare Kidney Disease: A Parent and Caregiver’s...

Nephrology ·

2024/11/01

Host: Gates B. Colbert, MD Guest: Kelly Helm Over 35 million people in the United States suffer from some form of chronic kidney disease, but many of them lack the support and education to navigate their condition and receive the best possible care. After her daughter was diagnosed with a rare kidney disease, Kelly Helm discovered the many obstacles associated with management and treatment. Hear from Kelly as she sits down with Dr. Gates Colbert to share what she’s learned as a

00:00:00

Uncovering New Biomarkers for RCC: A Review of...

Nephrology ·

2024/07/30

Host: Jody Takemoto, PhD Guest: David Braun Identifying biomarkers for renal cell carcinoma (RCC) is critical since they can help direct our therapeutic approach, which is why several techniques that may be able to uncover new biomarkers are currently being investigated. Joining Dr. Jody Takemoto to review those techniques and their potential impacts on RCC care is Dr. David Braun, Assistant Professor of Medicine and a member of the Center of Molecular and Cellular Oncology at Yale

00:00:00

The Potential Impact of RCC Molecular Subtypes on...

Nephrology ·

2024/07/29

Host: Jody Takemoto, PhD Guest: David Braun, MD, PhD A recent study investigated whether renal cell carcinoma (RCC) molecular subtypes have any impact on treatment outcomes. Here to share the surprising findings and their implications is Dr. David Braun, Assistant Professor of Medicine and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center.

00:00:00

Diabetes and CKD: Strategies for Diagnosis and Treatment

Nephrology ·

2024/05/21

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ian de Boer, MD Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. Tune in to hear Dr. Mary Katherine Cheeley discuss diabetes management in patients with chronic kidney disease with Dr. Ian de Boer, Professor of Medicine in the Division of Nephrology and the Director of

00:00:00

Extracorporeal Blood Purification in the Context of...

Nephrology ·

2024/04/23

Host: Kathleen Liu MD, PhD, FASN, BRCU Guest: Professor Claudio Ronco This episode dives into the recent advancements and best practices surrounding Extracorporeal Blood Purification within the complex scenario of multiorgan support. Join Drs. Kathleen Liu and Claudio Ronco as they engage in a thought-provoking discussion, exploring: Recent clinical trials suggesting minimal benefits of early CRRT in AKI for critically ill patients. The conversation delves into whether these

00:00:00

Stratifying the Risk of Persistent AKI and Clinical...

Nephrology ·

2024/04/23

Host: Kathleen Liu MD, PhD, FASN, BRCU Guest: Jay L. Koyner, MD In this episode of KDIGO Conversations in Nephrology, Dr. Kathleen Liu is joined by Dr. Jay Koyner to discuss the emerging field of persistent acute kidney injury (AKI). They delve into the question: what exactly is persistent AKI, and how does it differ from severe AKI? Dr. Liu and Dr. Koyner explore the key factors clinicians should consider when evaluating a patient's risk of developing persistent AKI. They also

00:00:00

Personalized Care for AKI – The Role of Digital...

Nephrology ·

2024/04/23

Host: Kathleen Liu MD, PhD, FASN, BRCU Guest: Kianoush B. Kashani MD, MS, MSc, FASN, FCCP In this episode, Dr. Kathleen Liu welcomes Dr. Kianoush Kashani to discuss the rising importance of personalized care in Acute Kidney Injury (AKI) treatment. They delve into the world of digital health, exploring how digital decision support tools can empower clinicians and improve patient outcomes. This episode will address: Digital Health: Dr. Kashani breaks down the concept of digital

00:00:00

Increasing CKD Awareness and Early Detection in Adult...

Nephrology ·

2024/04/10

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Christin Iroegbu PhD, RN If left untreated, chronic kidney disease (CKD) can progress to end-stage renal disease, requiring dialysis or kidney transplant as the only treatment options. So communicating this to patients, along with chronic conditions that could contribute to this are key. To learn more about raising awareness of the causes of CKD and to help slow the progression, join Dr. Mary Katherine Cheeley who’s

00:00:00

Improving CKD Patient Outcomes with SGLT2 Inhibitors

Nephrology ·

2024/03/14

Guest: Gates B. Colbert, MD, FASN A class of medications called SGLT2 inhibitors have been proven to make a major difference for patients with chronic kidney disease (CKD) with and without diabetes when added to angiotensin converting enzyme (ACE) and angiotensin receptor blockers (ARB) classes of medications. Several medications that have been well studied and approved by the FDA in the United States have shown progression of not only CKD but also cardiovascular events and overall

00:00:00

Improving CKD Awareness: Emphasizing the Risk in...

Nephrology ·

2024/02/20

Host: Ashley Baker, MSN, PMHNP Guest: Chi D. Chu, MD, MAS The National Health and Nutrition Examination Survey found that kidney disease awareness among patients in the U.S. is very low. And alarmingly, the proportion of awareness has not changed much over the 15-year period of this study. To uncover more of the findings and how to improve CKD awareness, tune into this discussion with Psychiatric Nurse Practitioner Ashley Baker as she takes a deep dive with Dr. Chi D. Chu,

00:00:00

CKD Evaluation & Measurement

Nephrology ·

2023/09/01

Host: Peter Lin MD, CCFP Guest: Magdalena Madero, MD In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Magdalena Madero (National Heart Institute Mexico City, Mexico) discuss best practices for CKD evaluation and measurement. This episode focuses on the importance of assessing GFR and albuminuria, identifying the causes of CKD, CKD progression, and when more accurate GFR measures (such as cystatin) should be conducted. This episode is supported by an

00:00:00

Applying CKD Interventions

Nephrology ·

2023/09/01

Host: Peter Lin MD, CCFP Guest: Joel Topf, MD Join host Dr. Peter Lin (Canadian Heart Research Centre, Canada) in conversation with Dr. Joel Topf (Oakland University, William Beaumont School of Medicine, USA) as they discuss how to combat CKD progression and the role of non-pharmacological vs pharmacological interventions. This episode will explore whether foundational therapies are underused and how to tailor the right treatment for the right patient at the right time. This

46 results

Nephrology

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe